GNL Gut and Liver
  1. Thaise Boeing, Francislaine Aparecida dos Reis Lívero, Priscila de Souza, Danielle Ayr Tavares de Almeida, Guilherme Donadel, Emerson Luiz Botelho Lourenço, Arquimedes Gasparotto Junior. Natural Products as Modulators of Mitochondrial Dysfunctions Associated with Cardiovascular Diseases: Advances and Opportunities. Journal of Medicinal Food 2023;26:279
    https://doi.org/10.1089/jmf.2022.0022
  2. Elena Moreno, Javier Martínez-Sanz, Rosa Martín-Mateos, Jorge Díaz-Álvarez, Sergio Serrano-Villar, Diego Burgos-Santamaría, Laura Luna, María Jesús Vivancos, Ana Moreno-Zamora, María Jesús Pérez-Elías, Santiago Moreno, Fernando Dronda, María Luisa Montes, Matilde Sánchez-Conde. Global DNA methylation and telomere length as markers of accelerated aging in people living with HIV and non-alcoholic fatty liver disease. BMC Genomics 2023;24
    https://doi.org/10.1186/s12864-023-09653-2
  3. A Lum Han. Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease. Diabetol Metab Syndr 2022;14
    https://doi.org/10.1186/s13098-022-00811-2
  4. Alessandro Mantovani, Alessandro Csermely, Herbert Tilg, Christopher D Byrne, Giovanni Targher. Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals. Gut 2023;72:1433
    https://doi.org/10.1136/gutjnl-2022-328224
  5. Ping Sun, Liping Huang, Ping Shuai, Zhengwei Wan, Yingying Liu, Jianqiang Xue, Yuping Liu. Effect of a High Protein, Low Glycemic Index Dietary Intervention on Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial. Front. Nutr. 2022;9
    https://doi.org/10.3389/fnut.2022.863834
  6. Wasit Wongtrakul, Natthinee Charatcharoenwitthaya, Phunchai Charatcharoenwitthaya. Metabolic dysfunction-associated steatotic liver disease and the risk of mortality in individuals with type 2 diabetes: a systematic review and meta-analysis. 2024;36:351
    https://doi.org/10.1097/MEG.0000000000002719
  7. Meng Li, Man Cui, Guoxia Li, Yueqiu Liu, Yunsheng Xu, Seyed Parsa Eftekhar, Moein Ala. The Pathophysiological Associations Between Obesity, NAFLD, and Atherosclerotic Cardiovascular Diseases. Horm Metab Res 2024;56:683
    https://doi.org/10.1055/a-2266-1503
  8. Xinyu Wang, Shuhang Wei, Yingnan Wei, Xueqi Wang, Feng Xiao, Yuemin Feng, Qiang Zhu. The impact of concomitant metabolic dysfunction-associated fatty liver disease on adverse outcomes in patients with hepatitis B cirrhosis: a propensity score matching study. 2023;35:889
    https://doi.org/10.1097/MEG.0000000000002583
  9. Eileen L. Yoon, Dae Won Jun. Waiting for Multi-Stakeholders’Consensus Position Statement on New Nonalcoholic Fatty Liver Disease Nomenclature. Gut and Liver 2022;16:319
    https://doi.org/10.5009/gnl220183
  10. Joon Ho Moon, Seogsong Jeong, Heejoon Jang, Bo Kyung Koo, Won Kim. Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study. eClinicalMedicine 2023;65:102292
    https://doi.org/10.1016/j.eclinm.2023.102292
  11. Min Kyung Park, Moon Haeng Hur, Hye‐Sung Moon, Hyunjae Shin, Sung Won Chung, Sungho Won, Yun Bin Lee, Eun Ju Cho, Jeong‐Hoon Lee, Su Jong Yu, Jung‐Hwan Yoon, Yoon Jun Kim. Extrahepatic malignancies in metabolic dysfunction‐associated fatty liver disease: A nationwide cohort study. Liver International 2024;44:799
    https://doi.org/10.1111/liv.15832
  12. Xiao-Dong Zhou, Jingjing Cai, Giovanni Targher, Christopher D. Byrne, Michael D. Shapiro, Ki-Chul Sung, Virend K. Somers, C. Anwar A. Chahal, Jacob George, Li-Li Chen, Yong Zhou, Ming-Hua Zheng. Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention. Cardiovasc Diabetol 2022;21
    https://doi.org/10.1186/s12933-022-01697-0
  13. Ya-Cong Zhang, Zhang-Yan Lyu, Bing Ma, Li-Min Li, Wei Wang, Chao Sheng, Hong-Ji Dai, Yu-Bei Huang, Fang-Fang Song, Feng-Ju Song, Ke-Xin Chen. A new risk stratification strategy for fatty liver disease by incorporating MAFLD and fibrosis score in a large US population. Hepatol Int 2022;16:835
    https://doi.org/10.1007/s12072-022-10362-3
  14. Shun-Yi Shi, Fang Jia, Meng-Fei Wang, Ya-Feng Zhou, Jian-Jun Li. Impacts of Non-alcoholic Fatty Liver Disease on Acute Coronary Syndrome: Evidence and Controversies. Curr Atheroscler Rep 2023;25:751
    https://doi.org/10.1007/s11883-023-01146-7
  15. Lei Liu, Yufu Zhou, Shuwen Deng, Ting Yuan, Saiqi Yang, Xiaoling Zhu, Changfa Wang, Yaqin Wang. Arterial stiffness progression in metabolic dysfunction–associated fatty liver disease subtypes: A prospective cohort study. Nutrition, Metabolism and Cardiovascular Diseases 2024;34:1890
    https://doi.org/10.1016/j.numecd.2024.03.030
  16. Lei Miao, Giovanni Targher, Christopher D. Byrne, Ying-Ying Cao, Ming-Hua Zheng. Current status and future trends of the global burden of MASLD. Trends in Endocrinology & Metabolism 2024;35:697
    https://doi.org/10.1016/j.tem.2024.02.007
  17. Carolina M. Perdomo, Jorge M. Núñez-Córdoba, Ana Ezponda, Francisco J. Mendoza, Javier Ampuero, Gorka Bastarrika, Gema Frühbeck, Javier Escalada. Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease. Front. Med. 2022;9
    https://doi.org/10.3389/fmed.2022.1023583
  18. Bo Kyung Koo, Soo Lim. Clinical Obesity in Adults and Children. 2022.
    https://doi.org/10.1002/9781119695257.ch13
  19. Pil Sook Park, Mei Sheng Li, Chong Yu Ding, Mi Yeon Park. Cardiocerebrovascular Disease or Fatty Liver Incidence Associated with Pattern of Metabolic Risk Factors and Nutritional Status of Korean Adults: A Prospective Cohort Study. J Health Info Stat 2023;48:165
    https://doi.org/10.21032/jhis.2023.48.2.165
  20. Cameron Gofton, Yadhavan Upendran, Ming-Hua Zheng, Jacob George. MAFLD: How is it different from NAFLD?. Clin Mol Hepatol 2023;29:S17
    https://doi.org/10.3350/cmh.2022.0367
  21. Ryusei Ohno, Hidehiro Kaneko, Yuta Suzuki, Akira Okada, Satoshi Matsuoka, Kensuke Ueno, Katsuhito Fujiu, Nobuaki Michihata, Taisuke Jo, Norifumi Takeda, Hiroyuki Morita, Koichi Node, Hideo Yasunaga, Issei Komuro. Association of Metabolic Dysfunction-Associated Fatty Liver Disease With Risk of HF and AF. JACC: Asia 2023;3:908
    https://doi.org/10.1016/j.jacasi.2023.08.003
  22. Karl Vaz, Daniel Clayton-Chubb, Ammar Majeed, John Lubel, David Simmons, William Kemp, Stuart K. Roberts. Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes. Hepatol Int 2023;17:1082
    https://doi.org/10.1007/s12072-023-10568-z
  23. Kai En Chan, Tiffany Jia Ling Koh, Ansel Shao Pin Tang, Jingxuan Quek, Jie Ning Yong, Phoebe Tay, Darren Jun Hao Tan, Wen Hui Lim, Snow Yunni Lin, Daniel Huang, Mark Chan, Chin Meng Khoo, Nicholas W S Chew, Apichat Kaewdech, Naichaya Chamroonkul, Yock Young Dan, Mazen Noureddin, Mark Muthiah, Mohammed Eslam, Cheng Han Ng. Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals. 2022;107:2691
    https://doi.org/10.1210/clinem/dgac321
  24. Mohammad Alomari, Mamoon Ur Rashid, Pravallika Chadalavada, Jonathan Ragheb, Hammad Zafar, Zoilo Karim Suarez, Shrouq Khazaaleh, Adalberto Jose Gonzalez, Fernando J Castro. Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes. World J Hepatol 2023;15:477
    https://doi.org/10.4254/wjh.v15.i4.477
  25. Yan Chen, Chuan Lu, Haonan Ju, Qingzhi Zhou, Xin Zhao. Elevated AIP is associated with the prevalence of MAFLD in the US adults: evidence from NHANES 2017–2018. Front. Endocrinol. 2024;15
    https://doi.org/10.3389/fendo.2024.1405828
  26. Myung Jin Kim, Yun Kyung Cho, Eun Hee Kim, Min Jung Lee, Woo Je Lee, Hong‐Kyu Kim, Chang Hee Jung. Association between metabolic dysfunction‐associated steatotic liver disease and myosteatosis measured by computed tomography. J cachexia sarcopenia muscle 2024;15:1942
    https://doi.org/10.1002/jcsm.13543
  27. Young Lee, Eun Ju Cho, Eun Kyung Choe, Min-Sun Kwak, Jong In Yang, Seung-Won Oh, Jeong Yoon Yim, Goh Eun Chung. Genome-wide association study of metabolic dysfunction-associated fatty liver disease in a Korean population. Sci Rep 2024;14
    https://doi.org/10.1038/s41598-024-60152-0
  28. Xiao-Dong Zhou, Giovanni Targher, Christopher D. Byrne, Virend Somers, Seung Up Kim, C. Anwar A. Chahal, Vincent Wai-Sun Wong, Jingjing Cai, Michael D. Shapiro, Mohammed Eslam, Philippe Gabriel Steg, Ki-Chul Sung, Anoop Misra, Jian-Jun Li, Carlos Brotons, Yuli Huang, George V. Papatheodoridis, Aijun Sun, Yusuf Yilmaz, Wah Kheong Chan, Hui Huang, Nahum Méndez-Sánchez, Saleh A. Alqahtani, Helena Cortez-Pinto, Gregory Y. H. Lip, Robert J. de Knegt, Ponsiano Ocama, Manuel Romero-Gomez, Marat Fudim, Giada Sebastiani, Jang Won Son, John D. Ryan, Ignatios Ikonomidis, Sombat Treeprasertsuk, Daniele Pastori, Monica Lupsor-Platon, Herbert Tilg, Hasmik Ghazinyan, Jerome Boursier, Masahide Hamaguchi, Mindie H. Nguyen, Jian-Gao Fan, George Boon-Bee Goh, Mamun Al Mahtab, Saeed Hamid, Nilanka Perera, Jacob George, Ming-Hua Zheng. An international multidisciplinary consensus statement on MAFLD and the risk of CVD. Hepatol Int 2023;17:773
    https://doi.org/10.1007/s12072-023-10543-8
  29. Vasileios Lekakis, George V. Papatheodoridis. Natural history of metabolic dysfunction-associated steatotic liver disease. European Journal of Internal Medicine 2024;122:3
    https://doi.org/10.1016/j.ejim.2023.11.005
  30. Clarissa Elysia Fu, Cheng Han Ng, Jie Ning Yong, Kai En Chan, Jieling Xiao, Benjamin Nah, Shirley Huey Shin Bong, Khin Maung Win, Aung Hlaing Bwa, Wen Hui Lim, Darren Jun Hao Tan, Rebecca Wenling Zeng, Nicholas Chew, Margaret L.P. Teng, Mohammad Shadab Siddiqui, Jude A. Oben, Arun J. Sanyal, Vincent Wai-Sun Wong, Mazen Noureddin, Mark Muthiah. A Meta-analysis on Associated Risk of Mortality in Nonalcoholic Fatty Liver Disease. Endocrine Practice 2023;29:33
    https://doi.org/10.1016/j.eprac.2022.10.007
  31. Hyoeun Kim, Chan Joo Lee, Sang Hoon Ahn, Kwan Sik Lee, Byoung Kwon Lee, Su Jung Baik, Seung Up Kim, Jung Il Lee. MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups. Dig Dis Sci 2022;67:4919
    https://doi.org/10.1007/s10620-022-07508-6
  32. Pengwei Zhang, Xianhui Dong, Wei Zhang, Shiyin Wang, Chen Chen, Jiake Tang, Yao You, Siqi Hu, Shenghui Zhang, Chunyi Wang, Wen Wen, Mengyun Zhou, Tao Tan, Guanming Qi, Li Li, Mingwei Wang. Metabolic-associated fatty liver disease and the risk of cardiovascular disease. Clinics and Research in Hepatology and Gastroenterology 2023;47:102063
    https://doi.org/10.1016/j.clinre.2022.102063
  33. Xu-Fen Zeng, Krista A. Varady, Xiang-Dong Wang, Giovanni Targher, Christopher D. Byrne, Reema Tayyem, Giovanni Latella, Ina Bergheim, Rodrigo Valenzuela, Jacob George, Carolyn Newberry, Ju-Sheng Zheng, Elena S. George, C. Wendy Spearman, Meropi D. Kontogianni, Danijela Ristic-Medic, Wilza Arantes Ferreira Peres, Gamze Yurtdaş Depboylu, Wanshui Yang, Xu Chen, Fredrik Rosqvist, Christos S. Mantzoros, Luca Valenti, Hannele Yki-Järvinen, Antonella Mosca, Silvia Sookoian, Anoop Misra, Yusuf Yilmaz, Won Kim, Yasser Fouad, Giada Sebastiani, Vincent Wai-Sun Wong, Fredrik Åberg, Yu Jun Wong, Pianhong Zhang, Francisco-Javier Bermúdez-Silva, Yan Ni, Monica Lupsor-Platon, Wah Kheong Chan, Nahum Méndez-Sánchez, Robert J. de Knegt, Shahinul Alam, Sombat Treeprasertsuk, Li Wang, Mulong Du, Tiejun Zhang, Ming-Lung Yu, Huijie Zhang, Xingshun Qi, Xin Liu, Kanokwan Pinyopornpanish, Yu-Chen Fan, Kaijun Niu, Josep C. Jimenez-Chillaron, Ming-Hua Zheng. The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus. Metabolism 2024;161:156028
    https://doi.org/10.1016/j.metabol.2024.156028
  34. Ji Woo Baek, Yeun Soo Yang, Keum Ji Jung, Heejin Kimm, So Young Kim, Sunmi Lee, Sun Ha Jee. Metabolic dysfunction-associated steatotic liver disease, liver fibrosis and risk of cardiovascular disease: A prospective cohort study. Nutrition, Metabolism and Cardiovascular Diseases 2024;34:2623
    https://doi.org/10.1016/j.numecd.2024.09.001
  35. Seung Mi Lee, Geum Joon Cho, Won Young Wi, Errol R. Norwitz, Bo Kyung Koo, Jeesun Lee, Young Mi Jung, Soo Heon Kwak, Chan-Wook Park, Jong Kwan Jun, Sae Kyung Joo, Min-Jeong Oh, Won Kim, Joong Shin Park. Metabolic dysfunction-associated fatty liver disease as a risk factor for adverse outcomes in subsequent pregnancy: a nationwide cohort study. Hepatol Int 2023;17:367
    https://doi.org/10.1007/s12072-022-10458-w
  36. Goh Eun Chung, Su Jong Yu, Jeong-Ju Yoo, Yuri Cho, Kyu-na Lee, Dong Wook Shin, Donghee Kim, Yoon Jun Kim, Jung-Hwan Yoon, Kyungdo Han, Eun Ju Cho. Lean or diabetic subtypes predict increased all-cause and disease-specific mortality in metabolic-associated fatty liver disease. BMC Med 2023;21
    https://doi.org/10.1186/s12916-022-02716-3
  37. Kengo Moriyama. Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Fatty Liver-Related Indices in a Japanese Population. Metabolic Syndrome and Related Disorders 2024;22:190
    https://doi.org/10.1089/met.2023.0212
  38. Pengwei Zhang, Yijun Zeng, Sijia Yang, Chunhong Ye, Mingwei Wang, Tianfang Peng, Li Li, Xianhui Dong. Mortality outcomes in diabetic metabolic dysfunction-associated fatty liver disease: non-obese versus obese individuals. Sci Rep 2024;14
    https://doi.org/10.1038/s41598-024-61896-5
  39. Ji Yeon Seo, Eun Ju Cho, Min Joo Kim, Min‐Sun Kwak, Jong In Yang, Su Jin Chung, Jeong Yoon Yim, Ji Won Yoon, Goh Eun Chung. The relationship between metabolic dysfunction‐associated fatty liver disease and low muscle mass in an asymptomatic Korean population. J cachexia sarcopenia muscle 2022;13:2953
    https://doi.org/10.1002/jcsm.13099
  40. Zhihao Wei, Zhe Huang, Zongshuang Song, Wenliu Zhao, Dandan Zhao, Yizhen Tan, Shuohua Chen, Peng Yang, Yun Li, Shouling Wu. Metabolic Dysfunction-associated fatty liver disease and incident heart failure risk: the Kailuan cohort study. Diabetol Metab Syndr 2023;15
    https://doi.org/10.1186/s13098-023-01102-0
  41. Tae Kyung Yoo, Mi Yeon Lee, Seong Hwan Kim, Ming-Hua Zheng, Giovanni Targher, Christopher D. Byrne, Ki-Chul Sung. Comparison of cardiovascular mortality between MAFLD and NAFLD: A cohort study. Nutrition, Metabolism and Cardiovascular Diseases 2023;33:947
    https://doi.org/10.1016/j.numecd.2023.01.013
  42. Gi-Ae Kim, Joon Ho Moon, Won Kim. Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity. Clin Mol Hepatol 2023;29:831
    https://doi.org/10.3350/cmh.2023.0277
  43. Zhi-Qin Xie, Hong-Xia Li, Bing-Kun Wang, Zhao-Ming Yang, Zi-Yu Zhang, Wen-Liang Tan, Wen-Xin Li, Qing-Bin Wang, Lei Yang, Hong-Kai Zhuang, Chen-Wei Tang, Chang-Zhen Shang, Ya-Jin Chen. Trends in prevalence and all-cause mortality of metabolic dysfunction-associated fatty liver disease among adults in the past three decades: Results from the NHANES study. European Journal of Internal Medicine 2023;110:62
    https://doi.org/10.1016/j.ejim.2023.01.029
© 2023. Gut and Liver. / Powered by INFOrang Co., Ltd